prednisolone has been researched along with Syndrome, VKH (Vogt Koyanagi Harada) in 72 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| " After prednisolone and methotrexate failed to have the desired effect, he was treated with azathioprine, which caused pancytopenia, and manifested as fever with positive blood culture for a coagulase-negative staphylococcus infection." | 8.12 | Azathioprine Induced Pancytopenia in a Patient with Vogt-Koyanagi-Harada Disease: A Case Report. ( Barman, P; Bhattarai, S; Khatri, S; Manandhar, D; Pyakurel, S; Regmi, S; Singh, AK, 2022) |
| " The complex immunological response to interferon and ribavirin may induce or exacerbate the autoimmune condition; however, VKH disease is a very rare complication associated with interferon therapy in chronic hepatitis C." | 7.77 | Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C. ( Jang, JY; Jeong, SW; Kim, HS; Kim, SG; Kim, YS; Lee, SH; Lee, YN; Lim, JH; Park, TK, 2011) |
| " After prednisolone and methotrexate failed to have the desired effect, he was treated with azathioprine, which caused pancytopenia, and manifested as fever with positive blood culture for a coagulase-negative staphylococcus infection." | 4.12 | Azathioprine Induced Pancytopenia in a Patient with Vogt-Koyanagi-Harada Disease: A Case Report. ( Barman, P; Bhattarai, S; Khatri, S; Manandhar, D; Pyakurel, S; Regmi, S; Singh, AK, 2022) |
| " The complex immunological response to interferon and ribavirin may induce or exacerbate the autoimmune condition; however, VKH disease is a very rare complication associated with interferon therapy in chronic hepatitis C." | 3.77 | Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C. ( Jang, JY; Jeong, SW; Kim, HS; Kim, SG; Kim, YS; Lee, SH; Lee, YN; Lim, JH; Park, TK, 2011) |
| "Prednisolone (200 mg/day) was systemically administered in 10 VKH disease patients with serous retinal detachment at the macular area." | 3.74 | Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease. ( Dong, Z; Hirose, S; Namba, K; Ohno, S; Saito, M; Saito, W; Satoh, H; Yoshida, K, 2008) |
| "To clarify the morphologic background of serous retinal detachment with multilobular dye pooling on fluorescein angiography (FA) in acute Vogt-Koyanagi-Harada (VKH) disease." | 3.74 | Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease. ( Kishi, S; Otani, T; Yamaguchi, Y, 2007) |
| "We present a case of fetal death in a 28-year-old pregnant woman being treated with intravenous prednisolone for VKH disease." | 3.74 | [Fetal death following high-dose systemic steroid therapy in a pregnant patient with Vogt-Koyanagi-Harada disease]. ( Ashida, T; Gotoh, N; Ohta, K; Oka, K; Yonezawa, H, 2007) |
| "To assess the clinical course, determine the efficacy and safety of oral methotrexate in the control of intraocular inflammation, and evaluate the outcomes of lensectomy-vitrectomy and goniosynechiolysis on pediatric VKH-associated panuveitis." | 3.73 | Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis. ( Aletaha, M; Dehghan, MH; Peyman, GA; Soheilian, M; Yazdani, S, 2006) |
| "Limb and truncal ataxia, vestibular dysfunction and perceptive deafness were observed." | 2.38 | [Each one case of Vogt-Koyanagi-Harada disease with vestibular and cerebellar ataxia, and multiple cranial nerve palsies]. ( Hiraki, Y; Kaji, M; Kuboshiro, T; Kuwasaki, N; Shoji, H, 1989) |
| "Serous retinal detachment was confirmed on optical coherence tomography (OCT) and fundus fluorescein angiography." | 1.43 | Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome. ( Chew, SK; Levy, J; Lim, LL; Rogers, S, 2016) |
| "At the first recurrence, 81% (13 patients) of exudative retinal detachments (ERD) were associated with an initial immunomodulatory treatment conducted ≤6 months (3." | 1.37 | Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease. ( Bodaghi, B; Cohen, D; Errera, MH; Fardeau, C; Gaudric, A; LeHoang, P; Navarro, A; Westcott, M, 2011) |
| "Seven patients with VKH syndrome (three men and four women) participated in the study (14 eyes)." | 1.36 | Usefulness of anterior chamber depth measurement for efficacy assessment of steroid pulse therapy in patients with Vogt-Koyanagi-Harada disease. ( Igarashi, A; Kamiya, K; Otsuki, T; Shimizu, K, 2010) |
| "Isolated anterior segment recurrence in VKH disease may occur concomitantly with subclinical choroidal inflammation and requires systemic therapy." | 1.35 | Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease. ( Bacsal, K; Chee, SP; Wen, DS, 2008) |
| " Cox-regression analysis showed that the duration of oral corticosteroid treatment for less than 6 months was the only significant risk factor for recurrence of VKH after adjustment for age, gender, and the initial dosage of oral corticosteroid treatment (adjusted odds ratio=8." | 1.35 | Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. ( Chan, CK; Chan, RP; Lai, TY; Lam, DS, 2009) |
| "However, in a pregnant patient with VKH syndrome, the effects of high-dose corticosteroids on the fetus are controversial." | 1.31 | Vogt-Koyanagi-Harada syndrome in a pregnant patient treated with high-dose systemic corticosteroids. ( Doi, M; Matsubara, H; Uji, Y, 2000) |
| " It is suggested that the dosage of corticosteroid should be adjusted according to the severity of uveomeningitis." | 1.26 | Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease. ( Hayasaka, S; Okabe, H; Takahashi, J, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (11.11) | 18.7374 |
| 1990's | 11 (15.28) | 18.2507 |
| 2000's | 27 (37.50) | 29.6817 |
| 2010's | 22 (30.56) | 24.3611 |
| 2020's | 4 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Shinagawa, M | 1 |
| Namba, K | 5 |
| Mizuuchi, K | 4 |
| Iwata, D | 3 |
| Hase, K | 1 |
| Suzuki, K | 2 |
| Hirooka, K | 4 |
| Kitaichi, N | 4 |
| Hiraoka, M | 1 |
| Ishida, S | 4 |
| Joo, CW | 1 |
| Kim, YK | 1 |
| Park, SP | 1 |
| Khatri, S | 2 |
| Regmi, S | 1 |
| Pyakurel, S | 1 |
| Bhattarai, S | 1 |
| Barman, P | 1 |
| Manandhar, D | 1 |
| Singh, AK | 1 |
| Concha-Del Rio, LE | 1 |
| Uribe-Reina, P | 1 |
| De-La-Torre, A | 1 |
| Zhou, M | 1 |
| Gu, RP | 1 |
| Sun, Z | 1 |
| Jiang, CH | 1 |
| Chang, Q | 1 |
| Xu, GZ | 1 |
| Amir, MM | 1 |
| Masood, A | 1 |
| Khan, Z | 1 |
| Hosoda, Y | 1 |
| Uji, A | 1 |
| Hangai, M | 2 |
| Morooka, S | 1 |
| Nishijima, K | 2 |
| Yoshimura, N | 3 |
| Yang, HK | 1 |
| Park, KH | 1 |
| Kim, JS | 1 |
| Hwang, JM | 1 |
| Caso, F | 1 |
| Rigante, D | 1 |
| Vitale, A | 1 |
| Costa, L | 1 |
| Bascherini, V | 1 |
| Latronico, E | 1 |
| Franceschini, R | 1 |
| Cantarini, L | 1 |
| Urzua, CA | 1 |
| Velasquez, V | 1 |
| Sabat, P | 1 |
| Berger, O | 1 |
| Ramirez, S | 1 |
| Goecke, A | 1 |
| Vásquez, DH | 1 |
| Gatica, H | 1 |
| Guerrero, J | 1 |
| Saito, W | 3 |
| Takemoto, Y | 2 |
| Uno, T | 2 |
| Tagawa, Y | 2 |
| Hashimoto, Y | 2 |
| Fukuhara, T | 1 |
| Ohno, S | 5 |
| Hashizume, K | 1 |
| Imamura, Y | 1 |
| Fujiwara, T | 1 |
| Machida, S | 1 |
| Ishida, M | 1 |
| Kurosaka, D | 1 |
| Arevalo, JF | 1 |
| Lasave, AF | 1 |
| Gupta, V | 1 |
| Kozak, I | 1 |
| Al Harbi, MB | 1 |
| Al Rushood, AA | 1 |
| Al Dhibi, HA | 1 |
| Chew, SK | 1 |
| Levy, J | 1 |
| Rogers, S | 1 |
| Lim, LL | 1 |
| Couto, C | 1 |
| Schlaen, A | 1 |
| Frick, M | 1 |
| Khoury, M | 1 |
| Lopez, M | 1 |
| Hurtado, E | 1 |
| Goldstein, D | 1 |
| Ibrahimagić, OĆ | 1 |
| Smajlović, D | 1 |
| Dostović, Z | 1 |
| Zvorničanin, J | 1 |
| Pašić, Z | 1 |
| Salihović Hajdarević, D | 1 |
| Horie, Y | 1 |
| Chee, SP | 3 |
| Jap, A | 2 |
| Bacsal, K | 2 |
| Hirose, S | 1 |
| Yoshida, K | 1 |
| Saito, M | 1 |
| Dong, Z | 1 |
| Satoh, H | 1 |
| Hashimoto, T | 1 |
| Takizawa, H | 1 |
| Yukimura, K | 1 |
| Ohta, K | 2 |
| Usui, Y | 1 |
| Goto, H | 1 |
| Sakai, J | 1 |
| Takeuchi, M | 1 |
| Usui, M | 1 |
| Rao, NA | 2 |
| Guo, YL | 1 |
| Du, Y | 1 |
| He, JF | 1 |
| Ishihara, K | 1 |
| Kita, M | 1 |
| Masuda, T | 1 |
| Kimura, N | 1 |
| Ishibashi, M | 1 |
| Ito, M | 1 |
| Takahashi, Y | 2 |
| Kumamoto, T | 1 |
| Keane, PA | 1 |
| Sadda, SR | 1 |
| Chan, EW | 1 |
| Sanjay, S | 1 |
| Chang, BC | 1 |
| Otsuki, T | 1 |
| Shimizu, K | 1 |
| Igarashi, A | 1 |
| Kamiya, K | 1 |
| Gao, X | 1 |
| Li, X | 1 |
| Errera, MH | 1 |
| Fardeau, C | 1 |
| Cohen, D | 1 |
| Navarro, A | 1 |
| Gaudric, A | 1 |
| Bodaghi, B | 1 |
| Westcott, M | 1 |
| LeHoang, P | 1 |
| Yamamoto, M | 1 |
| Nakamura, M | 1 |
| Lim, JH | 1 |
| Lee, YN | 1 |
| Kim, YS | 1 |
| Kim, SG | 1 |
| Jeong, SW | 1 |
| Jang, JY | 1 |
| Kim, HS | 1 |
| Lee, SH | 1 |
| Park, TK | 1 |
| Nakai, K | 1 |
| Gomi, F | 1 |
| Ikuno, Y | 1 |
| Yasuno, Y | 1 |
| Nouchi, T | 1 |
| Ohguro, N | 1 |
| Nishida, K | 1 |
| Iwata, NK | 1 |
| Hayashi, T | 1 |
| Numaga, J | 1 |
| Yamamichi, N | 1 |
| Sakurai, M | 1 |
| Kanazawa, I | 1 |
| Taylor, S | 1 |
| Lightman, S | 1 |
| Yang, MC | 1 |
| Huang, AJ | 1 |
| Kjeka, O | 1 |
| Krohn, J | 1 |
| Mawatari, Y | 1 |
| Hirata, A | 1 |
| Fukushima, M | 1 |
| Tanihara, H | 1 |
| Soheilian, M | 1 |
| Aletaha, M | 1 |
| Yazdani, S | 1 |
| Dehghan, MH | 1 |
| Peyman, GA | 1 |
| Luu, CD | 1 |
| Yeo, I | 1 |
| Agarwal, M | 1 |
| Ganesh, SK | 1 |
| Biswas, J | 1 |
| Yamaguchi, Y | 1 |
| Otani, T | 1 |
| Kishi, S | 1 |
| Yamamoto, Y | 1 |
| Yamazaki, T | 1 |
| Takano, S | 1 |
| Matsumura, A | 1 |
| Matsuo, T | 1 |
| Masuda, I | 1 |
| Ota, K | 1 |
| Yamadori, I | 1 |
| Sunami, R | 1 |
| Nose, S | 1 |
| Ostergaard, J | 1 |
| Goldschmidt, E | 1 |
| Andersen, N | 1 |
| Bennett, FM | 1 |
| Gotoh, N | 1 |
| Yonezawa, H | 1 |
| Oka, K | 1 |
| Ashida, T | 1 |
| Wen, DS | 1 |
| Lai, TY | 1 |
| Chan, RP | 1 |
| Chan, CK | 1 |
| Lam, DS | 1 |
| Hayasaka, S | 3 |
| Okabe, H | 1 |
| Takahashi, J | 1 |
| Gruich, MJ | 1 |
| Evans, OB | 1 |
| Storey, JM | 1 |
| Bradley, ST | 1 |
| Chen, CJ | 1 |
| Reusch, C | 1 |
| Chang, L | 1 |
| Minkus, G | 1 |
| Hammer, H | 1 |
| Janáky, M | 1 |
| Süveges, I | 1 |
| Ikeda, K | 1 |
| Suzuki, S | 1 |
| Ichijo, M | 1 |
| Matsuoka, Y | 1 |
| Irimajiri, S | 1 |
| Watanabe, K | 1 |
| Kato, T | 1 |
| Ikeda, N | 1 |
| Kadoi, C | 1 |
| Nagaki, Y | 1 |
| McDonald, HR | 1 |
| Doi, M | 1 |
| Matsubara, H | 1 |
| Uji, Y | 1 |
| Kotake, S | 1 |
| Mizue, Y | 1 |
| Sasamoto, Y | 2 |
| Goda, C | 1 |
| Iwabuchi, K | 1 |
| Onoé, K | 1 |
| Matsuda, H | 2 |
| Nishihira, J | 1 |
| Ishihara, M | 1 |
| Schalenbourg, A | 1 |
| Leys, A | 1 |
| De Courten, C | 1 |
| Coutteel, C | 1 |
| Herbort, CP | 1 |
| Lugossy, G | 1 |
| Martinez, JA | 1 |
| Lopez, PF | 1 |
| Sternberg, P | 1 |
| Aaberg, TM | 1 |
| Lambert, HM | 1 |
| Capone, A | 1 |
| Mandell, BA | 1 |
| Newman, NJ | 1 |
| Itho, S | 1 |
| Kurimoto, S | 1 |
| Kouno, T | 1 |
| Harada, T | 1 |
| Matsuzaki, S | 1 |
| Okada, H | 1 |
| Yumiyama, A | 1 |
| Majima, Y | 1 |
| Liao, HR | 1 |
| Juang, CJ | 1 |
| Hiraki, Y | 1 |
| Kuwasaki, N | 1 |
| Shoji, H | 1 |
| Kaji, M | 1 |
| Kuboshiro, T | 1 |
| Phanthumchinda, K | 1 |
| Kanchanapongkul, J | 1 |
| Locharernkul, C | 1 |
| Wakatsuki, Y | 1 |
| Kogure, M | 1 |
| Oguro, Y | 1 |
| Iversen, TH | 1 |
| Sverrisson, T | 1 |
4 reviews available for prednisolone and Syndrome, VKH (Vogt Koyanagi Harada)
| Article | Year |
|---|---|
Allergy against Steroids in Ocular Inflammation.
Topics: Adult; Conjunctivitis, Allergic; Drug Hypersensitivity; Female; Glucocorticoids; Humans; Prednisolon | 2021 |
[Case of Vogt-Koyanagi-Harada disease associated with non-herpetic acute limbic encephalitis with autoantibodies against glutamate receptor epsilon2 in the cerebrospinal fluid].
Topics: Adult; Autoantibodies; Female; Humans; Limbic Encephalitis; Magnetic Resonance Imaging; Prednisolone | 2009 |
[Vogt-Koyanagi-Harada disease].
Topics: Alleles; Autoimmunity; Diagnosis, Differential; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Melanocyte | 2000 |
[Each one case of Vogt-Koyanagi-Harada disease with vestibular and cerebellar ataxia, and multiple cranial nerve palsies].
Topics: Adult; Ataxia; Betamethasone; Cerebellar Ataxia; Cranial Nerve Diseases; Humans; Labyrinth Diseases; | 1989 |
68 other studies available for prednisolone and Syndrome, VKH (Vogt Koyanagi Harada)
| Article | Year |
|---|---|
The Steroid-Sparing Effect of Adalimumab in the Treatment for the Recurrent Phase of Vogt-Koyanagi-Harada Disease.
Topics: Adalimumab; Cyclosporine; Humans; Prednisolone; Retrospective Studies; Steroids; Uveomeningoencephal | 2023 |
Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination.
Topics: 2019-nCoV Vaccine mRNA-1273; COVID-19; Female; Humans; Middle Aged; Prednisolone; Retinal Detachment | 2022 |
Azathioprine Induced Pancytopenia in a Patient with Vogt-Koyanagi-Harada Disease: A Case Report.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Male; Middle Aged; Pancytopenia; Prednisolone; Uveom | 2022 |
Differences in photoreceptor recovery among patients and between different parts of the posterior pole in Vogt-Koyanagi-Harada disease.
Topics: Adult; Aged; Anti-Inflammatory Agents; Female; Fluorescein Angiography; Fovea Centralis; Humans; Mac | 2018 |
A Case of Vogt-Koyanagi-Harada Syndrome Mimicking Optic Neuritis.
Topics: Adult; Alopecia; Asian People; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; | 2018 |
Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Adolescent; Adult; Aged; Choroid Diseases; Cross-Sectional Studies; Dilatation, Patho | 2014 |
Bilateral disc edema in a patient with Vogt-Koyanagi-Harada disease.
Topics: Adult; Female; Fluorescein Angiography; Glucocorticoids; Humans; Magnetic Resonance Imaging; Papille | 2014 |
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; | 2015 |
Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease.
Topics: Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunomodulation; Immunosuppressi | 2015 |
Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt-Koyanagi-Harada disease.
Topics: Adult; Blood Flow Velocity; Choroid; Female; Fluorescein Angiography; Glucocorticoids; Humans; Infus | 2015 |
Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease.
Topics: Adolescent; Adult; Anterior Eye Segment; Child; Choroid; Female; Follow-Up Studies; Glucocorticoids; | 2016 |
RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Betamethasone; Biomarkers; Drug Combinations; Fema | 2016 |
Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antibiotics, Antitubercular; Child; Ch | 2016 |
Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids.
Topics: Adolescent; Adult; Choroid; Choroid Diseases; Female; Fluorescein Angiography; Glucocorticoids; Huma | 2015 |
Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome.
Topics: Administration, Oral; Adult; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Methylprednis | 2016 |
Adalimumab Treatment in Patients with Vogt-Koyanagi-Harada Disease.
Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents; Child; Female; Glucocorticoids; Humans; Imm | 2018 |
Vogt-Koyanagi-Harada syndrome and hyperhomocysteinemia: Is there a hidden link?
Topics: Autoimmune Diseases; Comorbidity; Electroencephalography; Humans; Hyperhomocysteinemia; Magnetic Res | 2017 |
Prompt therapy reduces the duration of systemic corticosteroids in Vogt-Koyanagi-Harada disease.
Topics: Asian People; Drug Administration Schedule; Glucocorticoids; Humans; Prednisolone; Uveomeningoenceph | 2008 |
Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore.
Topics: Adolescent; Adult; Age of Onset; Aged; Child; Child, Preschool; Female; Glucocorticoids; Humans; Mal | 2009 |
Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease.
Topics: Adult; Blood Flow Velocity; Choroid; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injec | 2008 |
Vogt-Koyanagi-Harada disease associated with brainstem encephalitis.
Topics: Adult; Anti-Inflammatory Agents; Brain Stem; Encephalitis; Humans; Magnetic Resonance Imaging; Male; | 2009 |
Presumed Vogt-Koyanagi-Harada disease with unilateral ocular involvement: report of three cases.
Topics: Adult; Aged; Choroid Diseases; Deafness; Female; Fluorescein Angiography; Follow-Up Studies; Glucoco | 2009 |
Correlation between sunset glow fundus and initial dosage of corticosteroid in patients with Vogt-Koyanagi-Harada disease.
Topics: Fundus Oculi; Glucocorticoids; Humans; Prednisolone; Prognosis; Retinal Pigment Epithelium; Risk Fac | 2009 |
Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography.
Topics: Acute Disease; Adult; Aged; Cysts; Female; Fluorescein Angiography; Glucocorticoids; Humans; Male; M | 2009 |
OCT interpretations.
Topics: Acute Disease; Cysts; Fluorescein Angiography; Glucocorticoids; Humans; Methylprednisolone; Predniso | 2010 |
Headache, red eyes, blurred vision and hearing loss. Diagnosis: Vogt-Koyanagi-Harada syndrome.
Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Female; Fluorescein Angiography; Hearing Loss, Se | 2010 |
Usefulness of anterior chamber depth measurement for efficacy assessment of steroid pulse therapy in patients with Vogt-Koyanagi-Harada disease.
Topics: Adult; Aged; Anterior Chamber; Axial Length, Eye; Body Weights and Measures; Drug Therapy, Combinati | 2010 |
Development of bullous retinal detachment during systemic corticosteroid treatment.
Topics: Administration, Oral; Central Serous Chorioretinopathy; Diagnostic Errors; Female; Fluorescein Angio | 2011 |
Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease.
Topics: Administration, Oral; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; | 2011 |
Inner retinal changes in acute-phase Vogt-Koyanagi-Harada disease measured by enhanced spectral domain optical coherence tomography.
Topics: Acute Disease; Adult; Female; Fluorescein Angiography; Glucocorticoids; Humans; Infusions, Intraveno | 2011 |
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Drug Therapy, Combination; Female; Fluorescein Angiograp | 2011 |
Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.
Topics: Acute Disease; Adult; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Glucocorti | 2012 |
Fits and deafness.
Topics: Adult; Anti-Inflammatory Agents; Brain; Deafness; Humans; Magnetic Resonance Imaging; Male; Meningoe | 2002 |
Recurrent anterior uveitis in patients with Vogt-Koyanagi-Harada syndrome.
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Age | 2004 |
Bilateral conjunctival nodules: an unusual manifestation of Vogt-Koyanagi-Harada syndrome.
Topics: Adult; Conjunctival Diseases; Diagnosis, Differential; Female; Glucocorticoids; Humans; Iridocycliti | 2004 |
[Vogt-Koyanagi-Harada disease].
Topics: Adolescent; Adult; Diagnosis, Differential; Female; Fluorescein Angiography; Glucocorticoids; Humans | 2005 |
Choroidal dye filling velocity in patients with Vogt-Koyanagi-Harada disease.
Topics: Adult; Betamethasone; Blood Circulation; Blood Flow Velocity; Choroid; Coloring Agents; Drug Therapy | 2006 |
Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis.
Topics: Administration, Oral; Adolescent; Cataract; Cataract Extraction; Child; Child, Preschool; Drug Thera | 2006 |
Correlation between peripapillary atrophy and corticosteroid therapy in patients with Vogt-Koyanagi-Harada disease.
Topics: Adult; Aged; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Drug Administration Schedul | 2008 |
Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Fundus Ocul | 2006 |
Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
Topics: Adolescent; Adult; Diagnosis, Differential; Dose-Response Relationship, Drug; Exudates and Transudat | 2007 |
[Case report of recurrent hydrocephalus due to uveo-meningeal syndrome].
Topics: Adult; Female; Humans; Hydrocephalus; Magnetic Resonance Imaging; Prednisolone; Recurrence; Treatmen | 2007 |
Vogt-Koyanagi-Harada syndrome in two patients with immunoglobulin A nephropathy.
Topics: Glomerulonephritis, IGA; Glucocorticoids; Humans; Male; Middle Aged; Prednisolone; Uveomeningoenceph | 2007 |
Vogt-Koyanagi-Harada syndrome in a Greenlandic Inuit.
Topics: Adult; Fundus Oculi; Genotype; Glucocorticoids; Greenland; HLA Antigens; Humans; Inuit; Male; Panuve | 2008 |
VOGT-KOYANAGI DISEASE.
Topics: Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Methylprednisolone; Methylprednis | 1962 |
[Fetal death following high-dose systemic steroid therapy in a pregnant patient with Vogt-Koyanagi-Harada disease].
Topics: Adult; Female; Fetal Death; Glucocorticoids; Humans; Prednisolone; Pregnancy; Pregnancy Complication | 2007 |
Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Anterior Eye Segment; Choroiditis; Color | 2008 |
Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Child; Drug Administration Schedule; E | 2009 |
Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Betamethasone; Female; Humans; Hydrocortisone; Male; Mid | 1982 |
Vogt-Koyanagi-Harada syndrome in a 4-year-old child.
Topics: Administration, Oral; Child, Preschool; Female; Fundus Oculi; Humans; Infusions, Intravenous; Mening | 1995 |
[Vogt-Koyanagi-Harada syndrome in an Akita-Inu dog. A case report].
Topics: Animals; Dexamethasone; Dog Diseases; Dogs; Drug Therapy, Combination; Male; Prednisolone; Uveomenin | 1994 |
Vogt-Koyanagi-Harada syndrome.
Topics: Adult; Cataract Extraction; Cyclosporine; Drug Therapy, Combination; Female; Humans; Prednisolone; U | 1993 |
How high is high in steroid treatment of Vogt-Koyanagi-Harada syndrome?
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Humans; Male; Prednisolone; Uveomeningoencephalitic | 1997 |
Concurrent bilateral posterior scleritis and Vogt-Koyanagi-Harada disease in a patient with positive rheumatoid factor.
Topics: Aged; Betamethasone; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Huma | 1997 |
Vogt-Koyanagi-Harada syndrome in an 11-year-old Boy.
Topics: Atropine; Child; Drug Therapy, Combination; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi | 1999 |
Diagnostic and therapeutic challenges.
Topics: Adult; Choroid; Choroiditis; Diagnosis, Differential; Fluorescein Angiography; Follow-Up Studies; Fu | 1999 |
Vogt-Koyanagi-Harada syndrome in a pregnant patient treated with high-dose systemic corticosteroids.
Topics: Adult; Dermoid Cyst; Ear; Eye Abnormalities; Female; Gestational Age; Glucocorticoids; Humans; Infan | 2000 |
High-dose corticosteroid administration induces increase of serum macrophage migration inhibitory factor in patients with Vogt-Koyanagi-Harada's disease.
Topics: Administration, Oral; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Glucocorticoids; H | 2000 |
Corticosteroid-induced central serous chorioretinopathy in patients with ocular inflammatory disorders.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Chorioretinitis; Cyclosporine; Drug Therapy, C | 2002 |
[Vogt-Koyanagi-Harada syndrome and cortisone].
Topics: Administration, Topical; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Female; Humans; Hydrocorti | 1976 |
Vogt-Koyanagi-Harada syndrome in patients with Cherokee Indian ancestry.
Topics: Adolescent; Adult; Female; Georgia; Haplotypes; Histocompatibility Testing; HLA Antigens; Humans; In | 1992 |
Vogt-Koyanagi-Harada disease in monozygotic twins.
Topics: Adult; Diseases in Twins; Female; Fluorescein Angiography; Fundus Oculi; Humans; Pedigree; Prednisol | 1992 |
[Occurrence of optic disk hemorrhage in the course of Vogt-Koyanagi-Harada syndrome].
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluorescein Angiography; Huma | 1991 |
Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease.
Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Anterior Chamber; Betamethasone | 1990 |
Formation of pseudodiscs in chronic recurrent Vogt-Koyanagi-Harada syndrome.
Topics: Adult; Choroid; Fluorescein Angiography; Humans; Male; Optic Disk; Prednisolone; Recurrence; Retinal | 1989 |
Vogt-Koyanagi-Harada syndrome.
Topics: Adult; Female; Humans; Male; Middle Aged; Prednisolone; Uveitis; Uveomeningoencephalitic Syndrome | 1989 |
Combination therapy with cyclosporin A and steroid in severe case of Vogt-Koyanagi-Harada's disease.
Topics: Cyclosporins; Drug Therapy, Combination; Humans; Male; Middle Aged; Prednisolone; Time Factors; Uvei | 1988 |
Vogt-Koyanagi-Harada syndrome. A case report.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Female; Fluoresce | 1986 |